{{Rsnum
|rsid=8177517
|Gene=SLC22A2
|Chromosome=6
|position=160242388
|Orientation=plus
|GMAF=0.01102
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=SLC22A2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 89.0 | 9.6 | 1.4
| ASW | 98.2 | 1.8 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 89.8 | 10.2 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 98.1 | 1.9 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs8177517
|Name_s=SLC22A2: K432Q
|Gene_s=SLC22A2
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=Increased sensitivity to inhibition by TBA in oocytes
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111566
}}

{{GET Evidence
|gene=SLC22A2
|aa_change=Lys432Gln
|aa_change_short=K432Q
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8177517
|overall_frequency_n=88
|overall_frequency_d=10758
|overall_frequency=0.00817996
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|pph2_score=0.067
|nblosum100=-2
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}